WRAP TECHNOLOGIES, INC. current report, 19 September 2023

Full document

WRAP TECHNOLOGIES, INC. - Form 8-K Summary

Business Context and Reporting Period

WRAP TECHNOLOGIES, INC. (Nasdaq: WRAP) filed this Current Report on September 19, 2023, to disclose the results of a Special Meeting of Stockholders held on that date. The meeting addressed proposals related to a securities offering and director participation.

Key Financial Metrics

This filing is a corporate governance report and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.

Material Changes and Voting Results

Stockholders voted on three proposals to comply with Nasdaq Listing Rules regarding a Securities Purchase Agreement dated June 29, 2023. All three proposals were approved by a majority of voting securities present.

  • Proposal 1 (Issuance Proposal): Authorized the issuance of Common Stock underlying convertible preferred stock and warrants in an amount exceeding 20% of outstanding shares.
    • For: 22,898,781
    • Against: 500,984
    • Abstain: 258,565
  • Proposal 2 (Director Participation Proposal): Approved the sale of convertible preferred stock and warrants to a director of the Company.
    • For: 22,867,304
    • Against: 558,782
    • Abstain: 232,244
  • Proposal 3 (Adjournment Proposal): Authorized the adjournment of the meeting if necessary to solicit further votes.
    • For: 22,909,958
    • Against: 568,534
    • Abstain: 179,838

Guidance, Outlook, and Risks

The filing does not contain management guidance, financial outlook, or specific risk factors. It references a definitive proxy statement filed on August 18, 2023, for detailed descriptions of the proposals and associated terms.

Key Facts for Investor Verification

  • Verify the terms of the Securities Purchase Agreement dated June 29, 2023, referenced in the Issuance Proposal.
  • Review the August 18, 2023 Proxy Statement for details on the director participating in the offering.
  • Confirm the impact of the approved issuance on total share count and potential dilution, as the issuance exceeds 20% of pre-offering outstanding shares.